Clinical Trials in Boston

Showing 3921-3940 of 17,836 trials

A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment

NCT04635111

A study to evaluate the long-term risk of hepatic failure with TURALIO™ (pexidartinib) and the mechanism of liver injury based upon optional liver biopsy information among patients who received or are receiving TURALIO™ (pexidartinib) and experience hepatotoxicity.

HepatotoxicityTenosynovial Giant Cell Tumor

Daiichi Sankyo30 participantsStarted Jan 2021

Santa Monica, California, United States • Santa Monica, California, United States • Santa Monica, California, United States +5 more locations

Active Not Recruiting< 1 mile

Identification of Predictors for Clinical Outcomes in Femoroacetabular Impingement Surgery

NCT04243447

The overarching goal of the study is to improve the surgical treatment outcomes of FAI, which is affecting an increasing number of military personnel and young active individuals in the general population. The proposed study will investigate critical patient, disease, and surgical treatment predictors of FAI surgery outcomes.

Femoracetabular Impingement

Washington University School of Medicine747 participantsStarted Feb 2020

Aurora, Colorado, United States • Iowa City, Iowa, United States • Boston, Massachusetts, United States +10 more locations

A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment

Identification of Predictors for Clinical Outcomes in Femoroacetabular Impingement Surgery

Find Trials by Condition in Boston

An Open-Label Extension Study of BPN14770 in Subjects With Fragile X Syndrome

BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study

MB-105 in Patients With CD5 Positive T-cell Lymphoma

Comparing Surgery Versus Standard Physical Therapy in Treating People With a Meniscal Tear and Osteoarthritis

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1

Expanded Access Protocol for Patients With Eosinophilic Esophagitis

Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients

Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD)

Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)

Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study)

Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates With Repeated Electroencephalographic Neonatal Seizures

Trial on Radical Upfront Surgery in Advanced Ovarian Cancer

Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors

A Study of Lenvatinib (MK-7902) in Pediatric Participants With Relapsed or Refractory Solid Malignancies (MK-7902-013/E7080)

A Study to Evaluate Single Agent Selinexor Versus Physician's Choice in Participants With Previously Treated Myelofibrosis